Trademark Overview
On Sunday, May 3, 2026, a trademark application was filed for BIOPHARMA EDGE with the United States Patent and Trademark Office. The USPTO has given the BIOPHARMA EDGE trademark a serial number of 99802111. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Sunday, May 3, 2026. The BIOPHARMA EDGE trademark is filed in the Insurance & Financial Services category with the following description:
Providing stock market information; Financial investment analysis and stock research; Providing information regarding financial investment strategies for individual investors focused on publicly traded biotechnology and pharmaceutical equities.